Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cue Biopharma Inc V.CUE


Primary Symbol: CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells. The Company's platform, Immuno-STAT (Selective Targeting and Alteration of T cells) and biologics are designed to harness the curative potential of the body's intrinsic immune system through the selective modulation of disease-specific T cells without the adverse effects of broad systemic immune modulation. Its two oncology drug product candidates, CUE-101 and CUE-102, are exemplary programs from the interleukin 2 (IL-2) based CUE-100 series, and are representative of the HLA-A02 allele, which is prevalent in the United States and western European territories. CUE-101 HLA-A02 is engineered for the treatment of human papillomavirus positive, head and neck squamous cell carcinoma (HNSCC). CUE-102 HLA-A02, targeting Wilms' Tumor 1 protein, an oncofetal antigen known to be over-expressed in more than 20 different cancers.


NDAQ:CUE - Post by User

Post by b00gn1shon Sep 13, 2008 7:01pm
1040 Views
Post# 15454622

$12,5000,000 third Cameco tranche

$12,5000,000 third Cameco trancheAppears that they are at most two steps away from receiving the third tranche of payment from Cameco.

I guess there will be a vote at the Sept 12 (scheduled) shareholders meeting to satisfy clause (v) of the terms below, and the only outstanding issue is a comprehensive strategic alliance agreement.  As far as I can tell, conditions (i) through (iv) have now been met.  It is unclear to me whether the shareholder meeting of 2007 sufficiently addressed condition (v), although I believe there was a vote on the matter of change of control which was at issue.  Also, it is unclear whether condition (vi) has been met, as the original terms suggest that a strategic alliance would be effective as of the date of the closing of tranche 1.  So, it could well be the case that all conditions have been met, and that all they are awaiting is the final approval of TSX for the private placement of tranche 3 with Cameco.

From the SEDAR filing of 09/06/07:

Cameco will subscribe by private placement for a number of units of Cue having an aggregate purchase price equal to the sum of US$4.5 Million and CDN$15.0 Million in three tranches as follows:

[...]

(c) a subscription for units having an aggregate purchase price of CDN$12,500,000 to close on the later of:

(i) January 31, 2008;

(ii) 30 days following completion of a drill program consisting of a minimum of 75 delineation holes from the Yuty Concessions and a column leach test being completed on the samples;

(iii) the delivery of an independent National Instrument 43-101 compliant report on the results of such drilling and testing programs with the results of the programs being satisfactory to Cameco in its sole discretion;

(iv) Transandes acquiring an exploitation work permit in respect of the portion of the Yuty Concessions designated as Yuty Block 2;

(v) Cue receiving shareholders’ approval of the third tranche of Cameco’s subscription for units of Cue; and

(vi) Cameco and Cue executing a comprehensive strategic alliance agreement.
<< Previous
Bullboard Posts
Next >>